Study: No Rise in Youth Cannabis Use Following Legalization
LOS ANGELES–The passing of both recreational or adult-use and medical cannabis legalization laws have not led to any uptick in youth consumption of cannabis, according to data published in the Journal of the American Medical Association.
Researchers analyzed data compiled from the Youth Risk Behavior Survey for the years 1993 to 2017.
They reported that the adoption of medical cannabis access laws was associated with slight reductions in self-reported cannabis use by young people. The enactment of adult-use legalization laws was associated with no statistically significant changes in youth use patterns.
Authors concluded, “Consistent with estimates from prior studies, there is little evidence that recreational cannabis laws or medical marijuana laws encourage youth marijuana use.”
Already dozens of federal and state-specific surveys have failed to identify any independent link between the legalization of cannabis for either adult-use or medical purposes and any rise in the percentage of teens using it. Moreover, data published in 2019 in the journal JAMA Pediatrics reported that the enactment of laws regulating the use of cannabis by adults is associated with declines in self-reported marijuana use by young people.
Other data compiled by the US Centers for Disease Control has reported that the number of adolescents admitted to drug treatment programs for marijuana-related issues has fallen precipitously in states that have legalized and regulated the adult-use market.
Nora Volkow, Director of the US National Institute on Drug Abuse similarly acknowledged that statewide legalization laws have not led to an increase in the prevalence of adolescents consuming cannabis.
Full text of the study, “Association of marijuana legalization with marijuana use among US high school students, 1993-2019,” appears in JAMA Open Network. Additional information regarding cannabis and teen use patterns is available from the NORML fact sheet, ‘Marijuana Regulation and Teen Use Rates.’
Reproduced with permission from NORML see original links here.
Latest News
Innocan Pharma Reports Significant Revenue Growth and Impressive Gross Profit in Q1 2023
LOS ANGELES-- Innocan Pharma Corporation, a pharmaceutical technology company specializing in innovative drug delivery platform technologies, has announced its financial results for the first quarter ended March 31, 2023. The company reported significant growth in ...
Minnesota Legalizes Adult-Use or Recreational Cannabis
ST PAUL, MN–Minnesota Governor Tim Walz, a Democrat, made a significant move on Tuesday by signing a bill that legalizes the recreational use of cannabis in the state. With this signature, Minnesota becomes the 23rd ...
Canopy Growth Acquires 19.99% Stake in Indiva, Secures Distribution Rights for Wana Edibles in Canada
LOS ANGELES-- In a strategic move to expand its presence in the cannabis edibles market, Canadian cannabis producer Canopy Growth has announced the acquisition of a 19.99% stake in edibles manufacturer Indiva. The deal also ...